NCT01618266View on ClinicalTrials.gov

Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

CompletedOBSERVATIONAL

Enrollment

375

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

October 31, 2014

Conditions

Macular EdemaRetinal Vein Occlusion

Interventions

DRUG

dexamethasone intravitreal implant

dexamethasone intravitreal implant 700 μg administered into the eye according to physician judgment.

Trial Locations (1)

Unknown

Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Allergan

INDUSTRY

NCT01618266 - Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter